comparemela.com

Page 15 - Curis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Curis (CRIS) Shares Are Nosediving Thursday - Curis (NASDAQ:CRIS)

Curis, Inc. (NASDAQ: CRIS) shares are trading lower by 8.29% to $0.75 Thursday morning after the company announced a $15.1 million registered direct offering.

Curis (CRIS) Prices 18 4M Share Offering at $0 82/sh

Curis (CRIS) Prices 18 4M Share Offering at $0 82/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

U S Food and Drug Administration Removes Partial Clinical Hold on Curis, Inc s TakeAim Leukemia Study RP2D Established At 300 Mg BID

Curis, Inc. announced that the U.S. Food and Drug Administration has removed the partial clinical hold on the TakeAim Leukemia Phase 1/2 study of emavusertib. Further, the recommended phase 2 dose .

Curis (CRIS) Announces FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

Curis (CRIS) Announces FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.